Peptides to Target Tumor Vasculature and Lymphatics for Improved Anti-Angiogenesis Therapy

Publisher： Bentham Science Publishers

E-ISSN： 1873-5576|16|6|522-535

ISSN： 1568-0096

Source： Current Cancer Drug Targets, Vol.16, Iss.6, 2016-07, pp. : 522-535

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Controlling the vasculature: angiogenesis, anti-angiogenesis and vascular targeting of gene therapy

By Fan T.-P.D.   Jaggar R.   Bicknell R.  

Trends in Pharmacological Sciences, Vol. 16, Iss. 2, 1995-02 ,pp. : 57-66

Elsevier

Access to resources Recommend Favorite

Activin receptor-like kinase 1 as a target for anti-angiogenesis therapy

By Hawinkels Lukas JAC   Garcia de Vinuesa Amaya   ten Dijke Peter  

Expert Opinion on Investigational Drugs, Vol. 22, Iss. 11, 2013-11 ,pp. : 1371-1383

Informa Healthcare

Access to resources Recommend Favorite

Implication of Heat Shock Protein 90 (HSP90) in Tumor Angiogenesis: A Molecular Target for Anti-Angiogenic Therapy?

By  

Current Cancer Drug Targets, Vol. 10, Iss. 8, 2010-12 ,pp. : 890-897

Bentham Science Publishers

Access to resources Recommend Favorite

Tumor vasculature as target for therapeutic intervention

By Fens Marcel HAM   Storm Gert   Schiffelers Raymond M  

Expert Opinion on Investigational Drugs, Vol. 19, Iss. 11, 2010-11 ,pp. : 1321-1338

Informa Healthcare

Access to resources Recommend Favorite

Antiangiogenesis Drug Design: Multiple Pathways Targeting Tumor Vasculature

By  

Current Medicinal Chemistry, Vol. 13, Iss. 8, 2006-04 ,pp. : 849-862

Bentham Science Publishers

Access to resources Recommend Favorite